Physician profile
Rafaela Thomas
NPI 1124068283
$1,188.12
in general payments reported to CMS, 2019-2025
8 companies · $398 in 2025
The $398 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $56.33 · 2022: $276 · 2023: $333 · 2024: $125 · 2025: $398.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $842 · Travel and Lodging: $13.78.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $842.10 |
| Travel and Lodging | $13.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $272.15 | 2023-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $248.44 | 2022-2024 | |
| Sanofi-Aventis U.S. LLC | $150.48 | 2022-2023 | |
| Merz North America, INC. | $126.21 | 2023 | Xeomin |
| Bayer Healthcare Pharmaceuticals INC. | $123.19 | 2025 | |
| Genentech USA, INC. | $121.84 | 2025 | Xolair |
| Evofem Biosciences, INC. | $89.48 | 2022 | |
| Scynexis, INC. | $56.33 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rafaela Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.